Thomson Medical Group Limited announced the resignation of executive director and group chief executive, Dr. Wong Chiang Yin, who is leaving to pursue personal interests. His last day will be on September 30, 2022. The board said it has identified a potential successor to Dr. Wong and will be making an announcement at an appropriate time.

Dr. Wong, who took on the group chief executive role in 2020, led the group through the Covid-19 pandemic. The board has appointed Lim Wee Kiat as executive vice-chairman. Lim, who is the son of the group's controlling shareholder Lim Eng Hock, currently oversees Thomson X, the group's digital arm.

Lim Wee Kiat's appointment as executive vice-chairman will be effective from September 1, 2022. He will be responsible for the group's overall growth strategies and will work with the board to grow Thomson Medical's business through mergers and acquisitions, particularly core hospital services in fast-growing South-east Asia economies.